Search - tctmd.com

Displaying 601 - 620 of 643

Sort: Relevancy | Date

Presentation TCT 2012

Renal Artery Stenting: What Are the Indications for Intervention in 2012?

Presenter: Christopher White

October 24, 2012

Presentation TCT 2012

Measuring the Clinical Effects of Renal Denervation: Are Office Blood Pressure and 24-Hour Ambulatory Blood Pressure Monitoring the Best Surrogates?

Presenter: Paul Sobotka

October 24, 2012

Presentation TCT 2012

Catheter-Based Technology Alternatives for Renal Denervation

Presenter: Horst Sievert

October 24, 2012

Presentation TCT 2012

Beyond Renal Denervation

Presenter: Paul Sobotka

October 24, 2012

Presentation TCT 2012

Beyond Hypertension: Future Prospects for Renal Denervation Therapy

Presenter: Paul Sobotka

October 24, 2012

Presentation TCT 2012

Approach to the Patient with Renal Failure and Multivessel CAD

Presenter: Harry Phillips

October 24, 2012

Presentation TCT 2012

TCT-9. Morphological Assessment of Renal Arteries After Radiofrequency Catheter-based Sympathetic Denervation in a Porcine Model

Presenter: Michael Joner

October 23, 2012

Presentation TCT 2012

TCT-15. Histo-morphometric Evaluation of 2D Characteristics and 3D Sympathetic Renal Nerve Distribution in Hypertensive vs. Normotensive Patients

Presenter: Giuseppe Sangiorgi

October 23, 2012

Presentation TCT 2012

TCT-14. Effects of Renal Sympathetic Denervation on Heart Rate and Atrioventricular Conduction in Patients with Resistant Hypertension

Presenter: Christian Ukena

October 23, 2012

Presentation TCT 2012

TCT-13. Renal Resistive Indices, Urinary Albumin Excretion and Renal Function in Patients with Resistant Hypertension After Catheter-based Renal Sympathetic Denervation

Presenter: Felix Mahfoud

October 23, 2012

Presentation TCT 2012

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

Presenter: Markus Schlaich

October 23, 2012

Presentation TCT 2012

TCT-11. Renal Sympathetic Denervation - Inducing an Instantaneous and Persisting 24h Ambulatory Blood Pressure Drop in Patients With Resistant Hypertension – Results from the...

Presenter: Alexander Plehn

October 23, 2012

Presentation TCT 2012

Hypertension: Renal Denervation

Presenter: Deepak Bhatt

October 23, 2012

Presentation TCT 2012

TCT-16. Renal Artery Nerve Distribution and Density in the Porcine Model: Biological Implications for the Development of Radiofrequency Ablation Therapies

Presenter: Armando Tellez

October 23, 2012

Presentation TCT 2012

TCT-10. Efficacy of Renal Denervation is Positively Impacted by Longitudinal Treatments

Presenter: Meital Mazor

October 23, 2012

News Conference News TCT 2012

STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting

October 23, 2012

News Conference News TCT 2012

PARTNER Shows Continued Benefits of TAVR, but STACCATO Introduces Questions About Transapical Use

October 23, 2012

Presentation TCT 2012

Essentials of Renal Artery Disease: Guidelines, Assessment, and Outcomes

Presenter: Jeffrey Olin

October 23, 2012

Presentation TCT 2012

Treating Fibromuscular Dysplasia in the Renal Artery

Presenter: Robert Lookstein

October 22, 2012

Presentation TCT 2012

Renal Sympathetic Denervation for HTN

Presenter: Lynne Hinterbuchner

October 22, 2012

Advertisement

Renal Artery Stenting: What Are the Indications for Intervention in 2012?

Measuring the Clinical Effects of Renal Denervation: Are Office Blood Pressure and 24-Hour Ambulatory Blood Pressure Monitoring the Best Surrogates?

Catheter-Based Technology Alternatives for Renal Denervation

Beyond Renal Denervation

Beyond Hypertension: Future Prospects for Renal Denervation Therapy

Approach to the Patient with Renal Failure and Multivessel CAD

TCT-9. Morphological Assessment of Renal Arteries After Radiofrequency Catheter-based Sympathetic Denervation in a Porcine Model

TCT-15. Histo-morphometric Evaluation of 2D Characteristics and 3D Sympathetic Renal Nerve Distribution in Hypertensive vs. Normotensive Patients

TCT-14. Effects of Renal Sympathetic Denervation on Heart Rate and Atrioventricular Conduction in Patients with Resistant Hypertension

TCT-13. Renal Resistive Indices, Urinary Albumin Excretion and Renal Function in Patients with Resistant Hypertension After Catheter-based Renal Sympathetic Denervation

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

TCT-11. Renal Sympathetic Denervation - Inducing an Instantaneous and Persisting 24h Ambulatory Blood Pressure Drop in Patients With Resistant Hypertension – Results from the...

Hypertension: Renal Denervation

TCT-16. Renal Artery Nerve Distribution and Density in the Porcine Model: Biological Implications for the Development of Radiofrequency Ablation Therapies

TCT-10. Efficacy of Renal Denervation is Positively Impacted by Longitudinal Treatments

STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting

PARTNER Shows Continued Benefits of TAVR, but STACCATO Introduces Questions About Transapical Use

Essentials of Renal Artery Disease: Guidelines, Assessment, and Outcomes

Treating Fibromuscular Dysplasia in the Renal Artery

Renal Sympathetic Denervation for HTN

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content